Sotera Health [SHC] vs Danaher [DHR] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Sotera Health Company wins in 9 metrics, Danaher Corporation wins in 11 metrics, with 0 ties. Danaher Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Sotera Health Company Danaher Corporation Better
P/E Ratio (TTM) 57.70 34.61 Danaher Corporation
Price-to-Book Ratio 7.31 2.40 Danaher Corporation
Debt-to-Equity Ratio 375.56 37.17 Danaher Corporation
PEG Ratio 0.29 3.84 Sotera Health Company
EV/EBITDA 11.50 17.69 Sotera Health Company
Profit Margin (TTM) 6.70% 14.89% Danaher Corporation
Operating Margin (TTM) 35.75% 22.94% Sotera Health Company
EBITDA Margin (TTM) 35.75% 22.94% Sotera Health Company
Return on Equity 15.42% 7.08% Sotera Health Company
Return on Assets (TTM) 8.18% 4.19% Sotera Health Company
Free Cash Flow (TTM) $149.18M $5.26B Danaher Corporation
Dividend Yield N/A 0.56% N/A
1-Year Return 27.78% -3.81% Sotera Health Company
Price-to-Sales Ratio (TTM) 3.82 5.10 Sotera Health Company
Enterprise Value $6.36B $140.38B Danaher Corporation
EV/Revenue Ratio 5.47 5.67 Sotera Health Company
Gross Profit Margin (TTM) 54.68% 60.34% Danaher Corporation
Revenue per Share (TTM) $4 $35 Danaher Corporation
Earnings per Share (Diluted) $0.27 $5.16 Danaher Corporation
Beta (Stock Volatility) 1.88 0.99 Danaher Corporation
Short % of Float 5.18% 1.10% Danaher Corporation

Sotera Health Company vs Danaher Corporation Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sotera Health Company1.96%-1.74%-0.78%-2.74%-9.32%-13.68%
Danaher Corporation4.81%2.86%2.32%-12.71%-22.05%-22.71%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sotera Health Company27.78%5.89%-37.69%-37.69%-37.69%-37.69%
Danaher Corporation-3.81%-12.18%-14.95%176.52%423.71%744.91%

Performance & Financial Health Analysis: Sotera Health Company vs Danaher Corporation

MetricSHCDHR
Market Information
Market Cap i$4.44B$126.39B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i2,339,8705,174,666
90 Day Avg. Volume i2,792,1534,357,215
Last Close$15.57$186.64
52 Week Range$10.80 - $19.85$160.93 - $242.80
% from 52W High-21.56%-23.13%
All-Time High$30.38 (Mar 15, 2021)$296.06 (Sep 06, 2021)
% from All-Time High-48.75%-36.96%
Growth Metrics
Quarterly Revenue Growth0.05%0.04%
Quarterly Earnings Growth1.83%0.08%
Financial Health
Profit Margin (TTM) i0.07%0.15%
Operating Margin (TTM) i0.36%0.23%
Return on Equity (TTM) i0.15%0.07%
Debt to Equity (MRQ) i375.5637.17
Cash & Liquidity
Book Value per Share (MRQ)$2.13$74.32
Cash per Share (MRQ)$1.21$8.06
Operating Cash Flow (TTM) i$287.20M$6.44B
Levered Free Cash Flow (TTM) i$236.80M$4.57B
Dividends
Last 12-Month Dividend Yield iN/A0.56%
Last 12-Month Dividend iN/A$1.28

Valuation & Enterprise Metrics Analysis: Sotera Health Company vs Danaher Corporation

MetricSHC (Apr 26, 2026)DHR (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i57.7034.61
Forward P/E i14.8919.64
PEG Ratio i0.293.84
Price to Sales (TTM) i3.825.10
Price to Book (MRQ) i7.312.40
Market Capitalization
Market Capitalization i$4.44B$126.39B
Enterprise Value i$6.36B$140.38B
Enterprise Value Metrics
Enterprise to Revenue i5.475.67
Enterprise to EBITDA i11.5017.69
Risk & Other Metrics
Beta i1.880.99
Book Value per Share (MRQ) i$2.13$74.32

Financial Statements Comparison: Sotera Health Company vs Danaher Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSHC (2025)DHR (2025)
Revenue/Sales i1.16B24.57B
Cost of Goods Sold i518.08M10.05B
COGS % of Revenue i44.5%40.9%
Gross Profit i645.53M14.52B
Gross Margin i55.5%59.1%
Research & Development iN/A1.60B
Operating Income (EBIT) i362.03M4.69B
Operating Margin i31.1%19.1%
EBITDA i507.29M7.17B
EBITDA Margin i43.6%29.2%
Pre-Tax Income i147.51M4.23B
Pre-Tax Income % of Revenue i12.7%17.2%
Income Tax i69.56M633.00M
Income Tax % of Revenue i6.0%2.6%
Net Income (Profit) i77.95M3.61B
Profit Margin i6.7%14.7%

Balance Sheet & Liquidity Metrics

MetricSHC (2025)DHR (2025)
Cash & Equivalents i344.62M4.62B
Total Current Assets i613.41M12.76B
Total Current Assets % of Revenue i52.7%51.9%
Total Current Liabilities i249.58M6.81B
Total Current Liabilities % of Revenue i21.4%27.7%
Long-Term Debt i2.25B19.50B
Long-Term Debt % of Revenue i193.4%79.4%
Total Shareholders Equity i606.04M52.54B
Retained Earnings i-532.09M46.89B
Retained Earnings % of Revenue i-45.7%190.9%
Property, Plant & Equipment i41.32M2.14B

Cash Flow Statement Comparison

MetricSHC (2025)DHR (2025)
Operating Cash Flow i276.60M5.64B
Operating Cash Flow % of Revenue i23.8%23.0%
Capital Expenditures i-138.02M-1.12B
Free Cash Flow i149.18M5.26B
FCF Margin i12.8%21.4%
Debt Repayment i-86.10M-500.00M
Common Stock Repurchase iN/A-3.09B

Short Interest & Institutional Ownership Analysis

MetricSHCDHR
Shares Short i12.81M6.94M
Short Ratio i4.401.68
Short % of Float i5.18%1.10%
Shares Outstanding i284.37M707.70M
Float Shares i191.73M630.65M
% Held by Insiders i2.32%10.78%
% Held by Institutions i85.40%85.08%
% Held by Public i12.28%4.14%

Dividend Analysis & Yield Comparison: Sotera Health Company vs Danaher Corporation

MetricSHCDHR
Last 12-Month Dividend iN/A$1.28
Last 12-Month Dividend Yield iN/A0.56%
3-Year Avg Annual Dividend iN/A$10.51
3-Year Avg Dividend Yield iN/A1.11%
3-Year Total Dividends iN/A$31.54
Ex-Dividend DateN/ADec 26, 2025